Botfet / Company detail

CORT

universe

Corcept Therapeutics Incorporated

biotech

Moat score54out of 100

The numbers

Financial metrics

Quality gate and thesis context

Roic6.7%

Gross Margin98.3%

Revenue Cagr20.1%

Fcf Conversion142.3%

Fcf Yield1.5%

Interest Coverage0.0x

Market Cap B$9.5B

Pe165.1

Quality PassPass

Founder LedNo

Thesis AlignedYes

Moat Quant54

Why it may endure

Moat breakdown

Quant: 54 · Curator: 0

Market Share Stability6

Network Effects6

Pricing Power20

Regulatory Moat16

Switching Costs6

Conviction0/10

Leadership0/10

Vision0/10

← Back to the full screener